The mitochondrial carrier homolog 2 is involved in down-regulation of influenza A virus replication.


Journal

Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 07 12 2023
accepted: 25 04 2024
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 10 5 2024
Statut: epublish

Résumé

The mitochondrial carrier homolog 2 (MTCH2) is a mitochondrial outer membrane protein regulating mitochondrial metabolism and functions in lipid homeostasis and apoptosis. Experimental data on the interaction of MTCH2 with viral proteins in virus-infected cells are very limited. Here, the interaction of MTCH2 with PA subunit of influenza A virus RdRp and its effects on viral replication was investigated. The human MTCH2 protein was identified as the influenza A virus PA-related cellular factor with the Y2H assay. The interaction between GST.MTCH2 and PA protein co-expressed in transfected HEK293 cells was evaluated by GST-pull down. The effect of MTCH2 on virus replication was determined by quantification of viral transcript and/or viral proteins in the cells transfected with MTCH2-encoding plasmid or MTCH2-siRNA. An interaction model of MTCH2 and PA was predicted with protein modeling/docking algorithms. It was observed that PA and GST.MTCH2 proteins expressed in HEK293 cells were co-precipitated by glutathione-agarose beads. The influenza A virus replication was stimulated in HeLa cells whose MTCH2 expression was suppressed with specific siRNA, whereas the increase of MTCH2 in transiently transfected HEK293 cells inhibited viral RdRp activity. The results of a Y2H assay and protein-protein docking analysis suggested that the amino terminal part of the viral PA (nPA) can bind to the cytoplasmic domain comprising amino acid residues 253 to 282 of the MTCH2. It is suggested that the host mitochondrial MTCH2 protein is probably involved in the interaction with the viral polymerase protein PA to cause negative regulatory effect on influenza A virus replication in infected cells.

Sections du résumé

BACKGROUND BACKGROUND
The mitochondrial carrier homolog 2 (MTCH2) is a mitochondrial outer membrane protein regulating mitochondrial metabolism and functions in lipid homeostasis and apoptosis. Experimental data on the interaction of MTCH2 with viral proteins in virus-infected cells are very limited. Here, the interaction of MTCH2 with PA subunit of influenza A virus RdRp and its effects on viral replication was investigated.
METHODS METHODS
The human MTCH2 protein was identified as the influenza A virus PA-related cellular factor with the Y2H assay. The interaction between GST.MTCH2 and PA protein co-expressed in transfected HEK293 cells was evaluated by GST-pull down. The effect of MTCH2 on virus replication was determined by quantification of viral transcript and/or viral proteins in the cells transfected with MTCH2-encoding plasmid or MTCH2-siRNA. An interaction model of MTCH2 and PA was predicted with protein modeling/docking algorithms.
RESULTS RESULTS
It was observed that PA and GST.MTCH2 proteins expressed in HEK293 cells were co-precipitated by glutathione-agarose beads. The influenza A virus replication was stimulated in HeLa cells whose MTCH2 expression was suppressed with specific siRNA, whereas the increase of MTCH2 in transiently transfected HEK293 cells inhibited viral RdRp activity. The results of a Y2H assay and protein-protein docking analysis suggested that the amino terminal part of the viral PA (nPA) can bind to the cytoplasmic domain comprising amino acid residues 253 to 282 of the MTCH2.
CONCLUSION CONCLUSIONS
It is suggested that the host mitochondrial MTCH2 protein is probably involved in the interaction with the viral polymerase protein PA to cause negative regulatory effect on influenza A virus replication in infected cells.

Identifiants

pubmed: 38727866
doi: 10.1007/s11033-024-09584-5
pii: 10.1007/s11033-024-09584-5
doi:

Substances chimiques

Mitochondrial Proteins 0
Viral Proteins 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

642

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Guna A, Stevens TA, Inglis AJ et al (2022) MTCH2 is a mitochondrial outer membrane protein insertase. Science 378(6617):317–322. https://doi.org/10.1126/science.add1856
doi: 10.1126/science.add1856 pubmed: 36264797 pmcid: 9674023
Palmieri F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777(7–8):564–578. https://doi.org/10.1016/j.bbabio.2008.03.008
doi: 10.1016/j.bbabio.2008.03.008 pubmed: 18406340
Palmieri F (2013) Mitochondrial metabolite carrier protein family. In: Lane MD, Lennarz WJ (eds) Encyclopedia of Biological Chemistry, 2nd edn. Academic, Waltham, pp 149–159
doi: 10.1016/B978-0-12-378630-2.00149-3
Schwarz M, Andrade-Navarro MA, Gross A (2007) Mitochondrial carriers and pores: key regulators of the mitochondrial apoptotic program? Apoptosis 12(5):869–876. https://doi.org/10.1007/s10495-007-0748-2
doi: 10.1007/s10495-007-0748-2 pubmed: 17453157
Zaltsman Y, Shachnai L, Yivgi-Ohana N et al (2010) MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. Nat Cell Biol 12(6):553–562. https://doi.org/10.1038/ncb2057
doi: 10.1038/ncb2057 pubmed: 20436477 pmcid: 4070879
Maryanovich M, Zaltsman Y, Ruggiero A et al (2015) An MTCH2 pathway repressing mitochondria metabolism regulates haematopoietic stem cell fate. Nat Commun 6:7901. https://doi.org/10.1038/ncomms8901
doi: 10.1038/ncomms8901 pubmed: 26219591
Rottiers V, Francisco A, Platov M et al (2017) MTCH2 is a conserved regulator of lipid homeostasis. Obes (Silver Spring) 25(3):616–625. https://doi.org/10.1002/oby.21751
doi: 10.1002/oby.21751
Ruggiero A, Aloni E, Korkotian E et al (2017) Loss of forebrain MTCH2 decreases mitochondria motility and calcium handling and impairs hippocampal-dependent cognitive functions. Sci Rep 7:44401. https://doi.org/10.1038/srep44401
doi: 10.1038/srep44401 pubmed: 28276496 pmcid: 5343590
Rozenblatt-Rosen O, Deo RC, Padi M et al (2012) Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487(7408):491–495. https://doi.org/10.1038/nature11288
doi: 10.1038/nature11288 pubmed: 22810586 pmcid: 3408847
Nainu F, Shiratsuchi A, Nakanishi Y (2017) Induction of apoptosis and subsequent phagocytosis of Virus-infected cells as an antiviral mechanism. Front Immunol 8:1220. https://doi.org/10.3389/fimmu.2017.01220
doi: 10.3389/fimmu.2017.01220 pubmed: 29033939 pmcid: 5624992
Rex DAB, Keshava Prasad TS, Kandasamy RK (2022) Revisiting regulated cell death responses in viral infections. Int J Mol Sci 23(13). https://doi.org/10.3390/ijms23137023
Ampomah PB, Lim LHK (2020) Influenza a virus-induced apoptosis and virus propagation. Apoptosis 25(1–2):1–11. https://doi.org/10.1007/s10495-019-01575-3
doi: 10.1007/s10495-019-01575-3 pubmed: 31667646
CaGlayan E, Turan K (2021) Expression profiles of interferon-related genes in cells infected with influenza A viruses or transiently transfected with plasmids encoding viral RNA polymerase. Turk J Biol 45(1):88–103. https://doi.org/10.3906/biy-2005-73
doi: 10.3906/biy-2005-73 pubmed: 33597825 pmcid: 7877717
Nayak DP, Hui EK, Barman S (2004) Assembly and budding of influenza virus. Virus Res 106(2):147–165. https://doi.org/10.1016/j.virusres.2004.08.012
doi: 10.1016/j.virusres.2004.08.012 pubmed: 15567494
Plotch SJ, Bouloy M, Krug RM (1979) Transfer of 5’-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A 76(4):1618–1622. https://doi.org/10.1073/pnas.76.4.1618
doi: 10.1073/pnas.76.4.1618 pubmed: 287003 pmcid: 383441
Krug RM, Morgan MA, Shatkin AJ (1976) Influenza viral mRNA contains internal N6-methyladenosine and 5’-terminal 7-methylguanosine in cap structures. J Virol 20(1):45–53. https://doi.org/10.1128/JVI.20.1.45-53.1976
doi: 10.1128/JVI.20.1.45-53.1976 pubmed: 1086370 pmcid: 354964
Plotch SJ, Tomasz J, Krug RM (1978) Absence of detectable capping and methylating enzymes in influenza virions. J Virol 28(1):75–83. https://doi.org/10.1128/JVI.28.1.75-83.1978
doi: 10.1128/JVI.28.1.75-83.1978 pubmed: 702657 pmcid: 354249
Shirayama R, Shoji M, Sriwilaijaroen N, Hiramatsu H, Suzuki Y, Kuzuhara T (2016) Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines. Drug Discov Ther 10(2):109–113. https://doi.org/10.5582/ddt.2016.01010
doi: 10.5582/ddt.2016.01010 pubmed: 26902927
Kim JH, Hatta M, Watanabe S, Neumann G, Watanabe T, Kawaoka Y (2010) Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. J Gen Virol 91(Pt 5):1284–1289. https://doi.org/10.1099/vir.0.018143-0
doi: 10.1099/vir.0.018143-0 pubmed: 20016035 pmcid: 2878586
Sakabe S, Takano R, Nagamura-Inoue T et al (2013) Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza a virus subtype H5N1. J Infect Dis 207(2):262–271. https://doi.org/10.1093/infdis/jis523
doi: 10.1093/infdis/jis523 pubmed: 23042757
James P, Halladay J, Craig EA (1996) Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144(4):1425–1436. https://doi.org/10.1093/genetics/144.4.1425
doi: 10.1093/genetics/144.4.1425 pubmed: 8978031 pmcid: 1207695
Nagata K, Saito S, Okuwaki M et al (1998) Cellular localization and expression of template-activating factor I in different cell types. Exp Cell Res 240(2):274–281. https://doi.org/10.1006/excr.1997.3930
doi: 10.1006/excr.1997.3930 pubmed: 9597000
Pham PTV, Turan K, Nagata K, Kawaguchi A (2018) Biochemical characterization of avian influenza viral polymerase containing PA or PB2 subunit from human influenza a virus. Microbes Infect 20(6):353–359. https://doi.org/10.1016/j.micinf.2018.04.003
doi: 10.1016/j.micinf.2018.04.003 pubmed: 29729434
Turan K, Mibayashi M, Sugiyama K, Saito S, Numajiri A, Nagata K (2004) Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res 32(2):643–652. https://doi.org/10.1093/nar/gkh192
doi: 10.1093/nar/gkh192 pubmed: 14752052 pmcid: 373319
Sugiyama K, Kawaguchi A, Okuwaki M, Nagata K (2015) pp32 and APRIL are host cell-derived regulators of influenza virus RNA synthesis from cRNA. Elife 4. https://doi.org/10.7554/eLife.08939
Sambrook J, Fritsch ER, Maniatis T (1989) Molecular cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press. In, Cold Spring Harbor, NY
Gietz RD, Schiestl RH (2007) Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc 2(1):38–41. https://doi.org/10.1038/nprot.2007.15
doi: 10.1038/nprot.2007.15 pubmed: 17401336
Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40. https://doi.org/10.1186/1471-2105-9-40
doi: 10.1186/1471-2105-9-40 pubmed: 18215316 pmcid: 2245901
Jumper J, Evans R, Pritzel A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596(7873):583–589. https://doi.org/10.1038/s41586-021-03819-2
doi: 10.1038/s41586-021-03819-2 pubmed: 34265844 pmcid: 8371605
Varadi M, Anyango S, Deshpande M et al (2022) AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res 50(D1):D439–D444. https://doi.org/10.1093/nar/gkab1061
doi: 10.1093/nar/gkab1061 pubmed: 34791371
Kozakov D, Hall DR, Xia B et al (2017) The ClusPro web server for protein-protein docking. Nat Protoc 12(2):255–278. https://doi.org/10.1038/nprot.2016.169
doi: 10.1038/nprot.2016.169 pubmed: 28079879 pmcid: 5540229
Fan H, Walker AP, Carrique L et al (2019) Structures of influenza a virus RNA polymerase offer insight into viral genome replication. Nature 573(7773):287–290. https://doi.org/10.1038/s41586-019-1530-7
doi: 10.1038/s41586-019-1530-7 pubmed: 31485076 pmcid: 6795553
Laskowski RA (2007) Enhancing the functional annotation of PDB structures in PDBsum using key figures extracted from the literature. Bioinformatics 23(14):1824–1827. https://doi.org/10.1093/bioinformatics/btm085
doi: 10.1093/bioinformatics/btm085 pubmed: 17384425
Xue LC, Rodrigues JP, Kastritis PL et al (2016) PRODIGY: a web server for predicting the binding affinity of protein-protein complexes. Bioinformatics 32(23):3676–3678. https://doi.org/10.1093/bioinformatics/btw514
doi: 10.1093/bioinformatics/btw514 pubmed: 27503228
Gross A (2005) Mitochondrial carrier homolog 2: a clue to cracking the BCL-2 family riddle? J Bioenerg Biomembr 37(3):113–119. https://doi.org/10.1007/s10863-005-6222-3
doi: 10.1007/s10863-005-6222-3 pubmed: 16167168
Ruprecht JJ, Kunji ERS (2020) The SLC25 mitochondrial carrier family: structure and mechanism. Trends Biochem Sci 45(3):244–258. https://doi.org/10.1016/j.tibs.2019.11.001
doi: 10.1016/j.tibs.2019.11.001 pubmed: 31787485
Kodym R, Kodym E, Story MD (2009) 2’-5’-Oligoadenylate synthetase is activated by a specific RNA sequence motif. Biochem Biophys Res Commun 388(2):317–322. https://doi.org/10.1016/j.bbrc.2009.07.167
doi: 10.1016/j.bbrc.2009.07.167 pubmed: 19665006
Chen G, Liu CH, Zhou L, Krug RM (2014) Cellular DDX21 RNA helicase inhibits influenza a virus replication but is counteracted by the viral NS1 protein. Cell Host Microbe 15(4):484–493. https://doi.org/10.1016/j.chom.2014.03.002
doi: 10.1016/j.chom.2014.03.002 pubmed: 24721576 pmcid: 4039189
Kocmar T, Caglayan E, Rayaman E, Nagata K, Turan K (2022) Human sorting nexin 2 protein interacts with Influenza A virus PA protein and has a negative regulatory effect on the virus replication. Mol Biol Rep 49(1):497–510. https://doi.org/10.1007/s11033-021-06906-9
doi: 10.1007/s11033-021-06906-9 pubmed: 34817777
McKellar J, Rebendenne A, Wencker M, Moncorge O, Goujon C (2021) Mammalian and avian host cell influenza a restriction factors. Viruses 13(3). https://doi.org/10.3390/v13030522
Almond JW (1977) A single gene determines the host range of influenza virus. Nature 270(5638):617–618. https://doi.org/10.1038/270617a0
doi: 10.1038/270617a0 pubmed: 593388
Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2 gene of influenza a virus is a determinant of host range. J Virol 67(4):1761–1764. https://doi.org/10.1128/JVI.67.4.1761-1764.1993
doi: 10.1128/JVI.67.4.1761-1764.1993 pubmed: 8445709 pmcid: 240216
Gao H, Sun H, Hu J et al (2015) Twenty amino acids at the C-terminus of PA-X are associated with increased influenza a virus replication and pathogenicity. J Gen Virol 96(8):2036–2049. https://doi.org/10.1099/vir.0.000143
doi: 10.1099/vir.0.000143 pubmed: 25877935 pmcid: 4681059
Gui R, Chen Q (2021) Molecular events involved in Influenza A Virus-Induced cell death. Front Microbiol 12:797789. https://doi.org/10.3389/fmicb.2021.797789
doi: 10.3389/fmicb.2021.797789 pubmed: 35069499
Chen W, Calvo PA, Malide D et al (2001) A novel influenza a virus mitochondrial protein that induces cell death. Nat Med 7(12):1306–1312. https://doi.org/10.1038/nm1201-1306
doi: 10.1038/nm1201-1306 pubmed: 11726970
Ehrhardt C, Wolff T, Pleschka S et al (2007) Influenza a virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81(7):3058–3067. https://doi.org/10.1128/JVI.02082-06
doi: 10.1128/JVI.02082-06 pubmed: 17229704 pmcid: 1866065
Zhirnov OP, Konakova TE, Wolff T, Klenk HD (2002) NS1 protein of influenza a virus down-regulates apoptosis. J Virol 76(4):1617–1625. https://doi.org/10.1128/jvi.76.4.1617-1625.2002
doi: 10.1128/jvi.76.4.1617-1625.2002 pubmed: 11799156 pmcid: 135891

Auteurs

Pınar Ulupinar (P)

Institute of Health Sciences, Marmara University, Istanbul, Turkey.

Elif Çağlayan (E)

University of Health Sciences, Kartal Koşuyolu High Speciality Educational and Research Hospital, Istanbul, Turkey.

Erkan Rayaman (E)

Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Marmara University, Istanbul, Turkey.

Kyosuke Nagata (K)

Department of Infection Biology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.

Kadir Turan (K)

Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. kadirturan@marmara.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH